Procaps Group Sa Stock Fundamentals
| PROC Stock | USD 1.11 0.54 94.74% |
Procaps Group SA fundamentals help investors to digest information that contributes to Procaps Group's financial success or failures. It also enables traders to predict the movement of Procaps Stock. The fundamental analysis module provides a way to measure Procaps Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Procaps Group stock.
At present, Procaps Group's Total Revenue is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 236.9 M, whereas Tax Provision is forecasted to decline to about 12.7 M. Procaps | Select Account or Indicator |
Procaps Group SA Company Return On Equity Analysis
Procaps Group's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Procaps Group Return On Equity | 0.37 |
Most of Procaps Group's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Procaps Group SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Procaps Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Procaps Group SA has a Return On Equity of 0.3737. This is 101.56% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The return on equity for all United States stocks is notably lower than that of the firm.
Procaps Group SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Procaps Group's current stock value. Our valuation model uses many indicators to compare Procaps Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Procaps Group competition to find correlations between indicators driving Procaps Group's intrinsic value. More Info.Procaps Group SA is regarded second in return on equity category among its peers. It also is regarded second in return on asset category among its peers reporting about 0.17 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Procaps Group SA is roughly 5.95 . At present, Procaps Group's Return On Equity is projected to decrease significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Procaps Group's earnings, one of the primary drivers of an investment's value.Procaps Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Procaps Group's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Procaps Group could also be used in its relative valuation, which is a method of valuing Procaps Group by comparing valuation metrics of similar companies.Procaps Group is currently under evaluation in return on equity category among its peers.
Procaps Fundamentals
| Return On Equity | 0.37 | ||||
| Return On Asset | 0.0628 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 389.32 M | ||||
| Shares Outstanding | 112.82 M | ||||
| Shares Owned By Insiders | 83.02 % | ||||
| Shares Owned By Institutions | 2.81 % | ||||
| Number Of Shares Shorted | 20.49 K | ||||
| Price To Book | 3.18 X | ||||
| Price To Sales | 0.30 X | ||||
| Revenue | 414.1 M | ||||
| Gross Profit | 191.31 M | ||||
| EBITDA | 57.06 M | ||||
| Net Income | 52.2 M | ||||
| Cash And Equivalents | 37.55 M | ||||
| Cash Per Share | 0.37 X | ||||
| Total Debt | 285.94 M | ||||
| Debt To Equity | 6.02 % | ||||
| Current Ratio | 1.54 X | ||||
| Book Value Per Share | 0.39 X | ||||
| Cash Flow From Operations | 62.99 M | ||||
| Short Ratio | 1.65 X | ||||
| Earnings Per Share | 0.51 X | ||||
| Target Price | 5.0 | ||||
| Number Of Employees | 5.5 K | ||||
| Beta | 0.17 | ||||
| Market Capitalization | 125.23 M | ||||
| Total Asset | 460.19 M | ||||
| Retained Earnings | (391.51 M) | ||||
| Working Capital | (70.93 M) | ||||
| Net Asset | 460.19 M |
About Procaps Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Procaps Group SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Procaps Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Procaps Group SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 32.3 M | 29.5 M | |
| Total Revenue | 414.1 M | 415.8 M | |
| Cost Of Revenue | 186.2 M | 178.9 M | |
| Stock Based Compensation To Revenue | (0.02) | (0.02) | |
| Sales General And Administrative To Revenue | 0.23 | 0.17 | |
| Research And Ddevelopement To Revenue | 0.01 | 0.01 | |
| Capex To Revenue | 0.07 | 0.05 | |
| Revenue Per Share | 3.65 | 2.81 | |
| Ebit Per Revenue | 0.15 | 0.11 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Procaps Group SA is a strong investment it is important to analyze Procaps Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Procaps Group's future performance. For an informed investment choice regarding Procaps Stock, refer to the following important reports:Check out Procaps Group Piotroski F Score and Procaps Group Altman Z Score analysis. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Procaps Group. If investors know Procaps will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Procaps Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.64) | Earnings Share 0.51 | Revenue Per Share 4.097 | Quarterly Revenue Growth 0.073 | Return On Assets 0.0628 |
The market value of Procaps Group SA is measured differently than its book value, which is the value of Procaps that is recorded on the company's balance sheet. Investors also form their own opinion of Procaps Group's value that differs from its market value or its book value, called intrinsic value, which is Procaps Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Procaps Group's market value can be influenced by many factors that don't directly affect Procaps Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Procaps Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if Procaps Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Procaps Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.